^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Title:

The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining

Published date:
12/09/2021
Excerpt:
Compared with TAM-sensitive counterparts, the expression levels of AKR1C1, AKR1C2, and AKR1C3 were up-regulated in TAM-resistant breast cancer cells.
DOI:
10.1186/s12885-021-09040-8